Business Description
PreveCeutical Medical Inc
NAICS : 325411
SIC : 3741
ISIN : CA74141E1043
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -25.82 | |||||
Debt-to-Equity | -0.7 | |||||
Debt-to-EBITDA | -37.78 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 34.1 | |||||
3-Year EPS without NRI Growth Rate | 33.1 | |||||
3-Year Book Growth Rate | 6.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.42 | |||||
9-Day RSI | 37.81 | |||||
14-Day RSI | 38.72 | |||||
12-1 Month Momentum % | -18.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.02 | |||||
Quick Ratio | 0.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.7 | |||||
Shareholder Yield % | -3.75 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | Neg. Equity | |||||
ROA % | 51.18 | |||||
ROIC % | -10.73 | |||||
ROC (Joel Greenblatt) % | -8250 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | N/A | |||||
PE Ratio without NRI | N/A | |||||
EV-to-EBIT | -155.99 | |||||
EV-to-EBITDA | -171.59 | |||||
EV-to-FCF | -76.95 | |||||
Earnings Yield (Greenblatt) % | -0.64 | |||||
FCF Yield % | -1.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
PreveCeutical Medical Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | 0 | ||
Beta | 1.59 | ||
Volatility % | 15.99 | ||
14-Day RSI | 38.72 | ||
14-Day ATR (€) | 0.000551 | ||
20-Day SMA (€) | 0.011225 | ||
12-1 Month Momentum % | -18.92 | ||
52-Week Range (€) | 0.01 - 0.0275 | ||
Shares Outstanding (Mil) | 535.3 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
PreveCeutical Medical Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
PreveCeutical Medical Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
PreveCeutical Medical Inc Frequently Asked Questions
What is PreveCeutical Medical Inc(FRA:18H)'s stock price today?
When is next earnings date of PreveCeutical Medical Inc(FRA:18H)?
Does PreveCeutical Medical Inc(FRA:18H) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |